on Medicure, Inc. (NASDAQ:MCUJF)
Medicure to Present Q3 2024 Financial Results Amid Board Changes
Medicure Inc., a company focused on pharmaceuticals and healthcare products in the United States, will present its Q3 2024 financial results on November 26, at 8:30 AM ET. The results will be filed after market closure on November 25. Stakeholders can access the conference call via toll-free and international numbers, or through a live webcast on their website.
The company also announced the resignation of board member Kimberly Kramchynsky, effective November 18, due to personal reasons. Albert Friesen, CEO, expressed gratitude for her contributions.
Medicure markets AGGRASTAT® and ZYPITAMAG® in the U.S., and operates Marley Drug Inc., offering medication access across all states, D.C., and Puerto Rico.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Medicure, Inc. news